• All Share : 51396.07
    DOWN -0.72%
    Top 40 : 4394.12
    DOWN -0.89%
    Financial 15 : 14558.94
    DOWN -0.20%
    Industrial 25 : 58799.66
    DOWN -0.74%

  • ZAR/USD : 10.7010
    UP 0.38%
    ZAR/GBP : 18.0701
    UP 0.23%
    ZAR/EUR : 14.3330
    UP 0.36%
    ZAR/JPY : 0.1042
    UP 0.52%
    ZAR/AUD : 9.9557
    UP 0.15%

  • Gold : 1283.0550
    DOWN -1.06%
    Platinum : 1462.2000
    DOWN -1.00%
    Silver : 20.4075
    DOWN -1.02%
    Palladium : 872.0000
    DOWN -0.34%
    Brent Crude Oil : 105.670
    DOWN -0.79%

  • All data is delayed by 15 min. Data supplied by INET BFA
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required